NCT03378635View on ClinicalTrials.gov

A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

April 27, 2018

Study Completion Date

May 25, 2018

Conditions
HypoglycemiaDiabetes Mellitus, Type 1
Interventions
DRUG

Dasiglucagon

Glucagon analog

DRUG

GlucaGen

Native glucagon

DRUG

Placebo

Placebo for dasiglucagon

Trial Locations (5)

91911

ProSciento, Chula Vista

Unknown

Clinical Research Center, Medizinische Universität Graz, Graz

LMC Diabetes & Manna Research, Toronto

Profil, Mainz

Profil, Neuss

Sponsors

Lead Sponsor

Zealand Pharma
All Listed Sponsors
lead

Zealand Pharma

INDUSTRY

NCT03378635 - A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects | Biotech Hunter | Biotech Hunter